Immunogen
The antiserum was produced against synthesized peptide derived from human RNF149. AA range:211-260
Specificity
RNF149 Polyclonal Antibody detects endogenous levels of RNF149 protein.
Formulation
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Dilution rate
IHC: 1/100 - 1/300. ELISA: 1/10000.. IF 1:50-200
Purification process (Immunogen)
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Background
domain:The RING-type zinc finger domain mediates binding to an E2 ubiquitin-conjugating enzyme.,pathway:Protein modification; protein ubiquitination.,similarity:Contains 1 PA (protease associated) domain.,similarity:Contains 1 RING-type zinc finger.,
Function
domain:The RING-type zinc finger domain mediates binding to an E2 ubiquitin-conjugating enzyme.,pathway:Protein modification; protein ubiquitination.,similarity:Contains 1 PA (protease associated) domain.,similarity:Contains 1 RING-type zinc finger.,
Protein name
E3 ubiquitin-protein ligase RNF149
Other name
RNF149; DNAPTP2; E3 ubiquitin-protein ligase RNF149; DNA polymerase-transactivated protein 2; RING finger protein 149
Human protein sequence Database
Q8NC42
Mouse protein sequence database
Q3U2C5
Rat protein sequence database
Cellular localization
Membrane ; Single-pass membrane protein .
Tissue expression
Brain,Cervix,Placenta,Teratocarcinoma,